Effects of the non-steroidal anti-inflammatory drug celecoxib on cholesterol containing distearoyl phosphatidylcholine membranes

Spectroscopy

Volumn 25, Issue 3-4, 2011, Pages 177-185

  Sade, Asli ^a   Banerjee, Sreeparna ^a   Severcan, Feride ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Celecoxib; cholesterol; DSPC; FTIR; MLV

Indexed keywords

ACYL CHAIN; ANTICANCER ACTIVITIES; CELECOXIB; DSPC; FTIR; HEAD GROUPS; INTERFACIAL REGION; LOW CONCENTRATIONS; MEMBRANE FLUIDITY; MEMBRANE SYSTEM; MEMBRANE-BOUND ENZYMES; MLV; MODEL MEMBRANES; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; PHOSPHATIDYLCHOLINE;

CHOLESTEROL; FLUIDITY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PHASE SEPARATION;

MEMBRANES;

CELECOXIB; CHOLESTEROL; DISTEAROYLPHOSPHATIDYLCHOLINE;

ARTICLE; ARTIFICIAL MEMBRANE; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG MECHANISM; HYDRATION; INFRARED SPECTROSCOPY; MEMBRANE FLUIDITY;

EID: 79959214919     PISSN: 07124813     EISSN: 1875922X     Source Type: Journal    
DOI: 10.3233/SPE-2011-0506     Document Type: Article

References (34)

1. Z. Arsov and L. Quaroni, Direct interaction between cholesterol and phosphatidylcholines in hydrated membranes revealed by ATR-FTIR spectroscopy, Chemistry and Physics of Lipids 150 (2007), 35-48. (Pubitemid 47538547)
2. M.S. Awayda, W.J. Shao, F.L. Guo, M. Zeidel and W.G. Hill, ENaC-Membrane interactions: Regulation of channel activity by membrane order, Journal of General Physiology 123 (2004), 709-727. (Pubitemid 38781376)
3. M.M. Bertagnolli, C.J. Eagle, A.G. Zauber, M. Redston, S.D. Solomon, K.M. Kim, J. Tang, R.B. Rosenstein, J. Wittes, D. Corle, T.M. Hess, G.M. Woloj, F. Boisserie, W.F. Anderson, J.L. Viner, D. Bagheri, J. Burn, D.C. Chung, T. Dewar, T.R. Foley, N. Hoffman, F. Macrae, R.E. Pruitt, J.R. Saltzman, B. Salzberg, T. Sylwestrowicz, G.B. Gordon, E.T. Hawk and APC Study Investigators, Celecoxib for the prevention of sporadic colorectal adenomas, New England Journal of Medicine 355 (2006), 873-884. (Pubitemid 44315980)
4. H.L. Casal, D.G. Cameron, I.C.P. Smith and H.H. Mantsch, Acholeplasma-laidlawii membranes-Fourier-transform infrared study of the influence of protein on lipid organization and dynamics, Biochemistry 19 (1980), 444-451.
5. H.L. Casal and H.H. Mantsch, Polymorphic phase-behavior of phospholipid-membranes studied by infrared-spectroscopy, Biochimica et Biophysica Acta 779 (1984), 381-401.
6. C.F. Chen and C.P. Tripp, An infrared spectroscopic based method to measure membrane permeance in liposomes, Biochimica et Biophysica Acta-Biomembranes 1778 (2008), 2266-2272.
7. R.A. Demel and B. Dekruyff, Function of sterols in membranes, Biochimica et Biophysica Acta 457 (1976), 109-132.
8. A. Deniz, A. Sade, F. Severcan, D. Keskin, A. Tezcaner and S. Banerjee, Celecoxib loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics, Bioscience Reports 30 (2010), 365-373.
9. C.D. Funk, Prostaglandins and leukotrienes: Advances in eicosanoid biology, Science 294 (2001), 1871-1875. (Pubitemid 33101574)
10. M. Gamerdinger, A.B. Clement and C. Behl, Cholesterol-like effects of selective cyclooxygenase inhibitors and fibrates on cellular membranes and amyloid-beta production, Molecular Pharmacology 72 (2007), 141-151. (Pubitemid 46998533)
11. M.M. Goldenberg, Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and os-teoarthritis, Clinical Therapeutics 21 (1999), 1497-1513. (Pubitemid 29449551)
12. S. Grosch, T.J. Maier, S. Schiffmann and G. Geisslinger, Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors, Journal of the National Cancer Institute 98 (2006), 736-747. (Pubitemid 43983297)
13. R.E. Harris, J. Beebe-Donk and G.A. Alshafie, Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors, BMC Cancer 6 (2006).
14. R.E. Harris, J. Beebe-Donk and G.A. Alshafie, Reduced risk of human lung cancer by selective cyclooxygenase 2 (Cox-2) blockade: Results of a case control study, International Journal of Biological Sciences 3 (2007), 328-334. (Pubitemid 46953958)
15. N. Kazanci, N. Toyran, P.I. Haris and F. Severcan, Vitamin D-2 at high and low concentrations exert opposing effects on molecular order and dynamics of dipalmitoyl phosphatidylcholine membranes, Spectroscopy-An International Journal 15 (2001), 47-55. (Pubitemid 32959998)
16. R.A. Knazek, S.C. Liu, J.R. Dave, R.J. Christy and J.A. Keller, Indomethacin causes a simultaneous decrease of both prolactin binding and fluidity of mouse-liver membranes, Prostaglandins and Medicine 6 (1981), 403-411. (Pubitemid 11153619)
17. F. Korkmaz and F. Severcan, Effect of progesterone on DPPC membrane: Evidence for lateral phase separation and inverse action in lipid dynamics, Archives of Biochemistry and Biophysics 440 (2005), 141-147. (Pubitemid 41140378)
18. F. Lopezgarcia, V. Micol, J. Villalain and J.C. Gomezfernandez, Infrared spectroscopic study of the interaction of diacyl-glycerol with phosphatidylserine in the presence of calcium, Biochimica et Biophysica Acta 1169 (1993), 264-272. (Pubitemid 23264883)
19. M. Lucio, H. Ferreira, J. Lima, C. Matos, B. de Castro and S. Reis, Influence of some anti-inflammatory drugs in membrane fluidity studied by fluorescence anisotropy measurements, Physical Chemistry Chemical Physics 6 (2004), 1493-1498.
20. F.R. Maxfield and I. Tabas, Role of cholesterol and lipid organization in disease, Nature 438 (2005), 612-621. (Pubitemid 41740565)
21. T.J. McIntosh, Effect of cholesterol on structure of phosphatidylcholine bilayers, Biochimica et Biophysica Acta 513 (1978), 43-58. (Pubitemid 9025754)
22. A. Sade, S. Banerjee and F. Severcan, Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles, Journal of Liposome Research 20 (2010), 168-177.
23. F. Severcan, H.O. Durmus, F. Eker, B.G. Akinoglu and P.I. Haris, Vitamin D-2 modulates melittin-membrane interactions, Talanta 53 (2000), 205-211.
24. F. Severcan, N. Kazanci, U. Baykal and S. Suzer, IR and turbidity studies of vitamin-E-cholesterol-phospholipid membrane interactions, Bioscience Reports 15 (1995), 221-229.
25. F. Severcan, N. Kazanci and F. Zorlu, Tamoxifen increases membrane fluidity at high concentrations, Bioscience Reports 20 (2000), 177-184.
26. F. Severcan, I. Sahin and N. Kazanci, Melatonin strongly interacts with zwitterionic model membranes-evidence from Fourier transform infrared spectroscopy and differential scanning calorimetry, Biochimica et Biophysica Acta-Biomem-branes 1668 (2005), 215-222. (Pubitemid 40298925)
27. W. Tomisato, K. Tanaka, T. Katsu, H. Kakuta, K. Sasaki, S. Tsutsumi, T. Hoshino, M. Aburaya, D.W. Li, T. Tsuchiya, K. Suzuki, K. Yokomizo and T. Mizushima, Membrane permeabilization by non-steroidal anti-inflammatory drugs, Biochemical and Biophysical Research Communications 323 (2004), 1032-1039. (Pubitemid 39243422)
28. J.R. Vane, Y.S. Bakhle and R.M. Botting, Cyclooxygenases 1 and 2, Annual Review of Pharmacology and Toxicology 38 (1998), 97-120. (Pubitemid 28231490)
29. G. Vanginkel, H. Vanlangen and Y.K. Levine, The membrane fluidity concept revisited by polarized fluorescence spec-troscopy on different model membranes containing unsaturated lipids and sterols, Biochimie 71 (1989), 23-32. (Pubitemid 19065439)
30. J. Villalain, F.J. Aranda and J.C. Gomezfernandez, Calorimetric and infrared spectroscopic studies of the interaction of alpha-tocopherol and alpha-tocopheryl acetate with phospholipid-vesicles, European Journal of Biochemistry 158 (1986), 141-147. (Pubitemid 16066515)
31. M.R. Vist and J.H. Davis, Phase-equilibria of cholesterol dipalmitoylphosphatidylcholine mixtures-H-2 nuclear magnetic-resonance and differential scanning calorimetry, Biochemistry 29 (1990), 451-464. (Pubitemid 20037653)
32. M.F. Walter, R.F. Jacob, C.A. Day, R. Dahlborg, Y.J. Weng and R.P. Mason, Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs, Atherosclerosis 177 (2004), 235-243. (Pubitemid 39505253)
33. P.L. Yeagle, Cholesterol and the cell-membrane, Biochimica et Biophysica Acta 822 (1985), 267-287.
34. P.L. Yeagle, W.C. Hutton, C.H. Huang and R.B. Martin, Headgroup conformation and lipid-cholesterol association in phosphatidylcholine vesicles-P-31(H-1) nuclear overhauser effect study, Proceedings of the National Academy of Sciences of the United States of America 72 (1975), 3477-3481.